Market Capitalization (Millions $) |
2,159 |
Shares
Outstanding (Millions) |
125 |
Employees |
2,000 |
Revenues (TTM) (Millions $) |
530 |
Net Income (TTM) (Millions $) |
-126 |
Cash Flow (TTM) (Millions $) |
-30 |
Capital Exp. (TTM) (Millions $) |
33 |
Neogenomics Inc
We run a network of cancer testing labs in the United States, Europe, and Asia. Our objective is to improve patient care by providing outstanding cancer-focused diagnostic services. Our aim is to be the worlds premier cancer testing and information company by providing unrivaled quality, great service, and cutting-edge solutions.
Company Address: 9490 NeoGenomics Way, Fort Myers, 33912 FL
Company Phone Number: 768-0600 Stock Exchange / Ticker: NASDAQ NEO
NEO is expected to report next financial results on August 08, 2023. |
|
|